Voyager Therapeutics (VYGR) Current Leases (2019 - 2025)
Historic Current Leases for Voyager Therapeutics (VYGR) over the last 7 years, with Q3 2025 value amounting to $7.8 million.
- Voyager Therapeutics' Current Leases rose 1245.16% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 1245.16%. This contributed to the annual value of $7.2 million for FY2024, which is 12584.37% up from last year.
- According to the latest figures from Q3 2025, Voyager Therapeutics' Current Leases is $7.8 million, which was up 1245.16% from $7.6 million recorded in Q2 2025.
- Voyager Therapeutics' Current Leases' 5-year high stood at $7.8 million during Q3 2025, with a 5-year trough of $2.5 million in Q2 2022.
- For the 5-year period, Voyager Therapeutics' Current Leases averaged around $5.1 million, with its median value being $5.2 million (2021).
- Per our database at Business Quant, Voyager Therapeutics' Current Leases tumbled by 4916.53% in 2022 and then soared by 12584.37% in 2024.
- Over the past 5 years, Voyager Therapeutics' Current Leases (Quarter) stood at $5.6 million in 2021, then crashed by 49.17% to $2.8 million in 2022, then increased by 12.99% to $3.2 million in 2023, then soared by 125.84% to $7.2 million in 2024, then rose by 8.59% to $7.8 million in 2025.
- Its Current Leases stands at $7.8 million for Q3 2025, versus $7.6 million for Q2 2025 and $7.4 million for Q1 2025.